      Document 0056
 DOCN  DRG0056
 UNIQUE IDENTIFIER        DRG-0191
 NAME OF SUBSTANCE        Anti-Rh antibodies [NCI 93 C-155]
 SYNONYMS                 Anti-D [NCI 93 C-155]
 PROTOCOL ID NUMBERS      NCI 93 C-155
 SECONDARY SOURCE ID      DRG
 DISEASES STUDIED/TREATED HIV-associated thrombocytopenia [NCI 93
                          C-155]
 CLASSIFICATION CODE      Immunomodulator [NCI 93 C-155]
 SUBSTANCE DELIVERY DATA  MODE OF DELIVERY: Intravenous. [NCI 93 C-155]
 MANUFACTURERS            Participating Unit Provides This Drug
 REFERENCES               Mascarin M, Trovo MG, Ventura A. [Anti-Rh(D):
                          an efficacious therapeutic alternative in
                          autoimmune hemocytopenias.] Pediatr Med Chir.
                          1993 Jul-Aug;15(4):349-52.
 REFERENCES               Pinier Y, Pradier C, Bernard E, Durant J,
                          Dellamonica P. Interest of anti-D
                          immunoglobulins (IgG) for treatment of AIDS
                          or ARC patients with severe thrombopenia. Int
                          Conf AIDS. 1992 Jul 19-24;8(3):121 (abstract
                          no. PuB 7437).
 REFERENCES               Gringeri A, Cattaneo M, Santagostino E,
                          Mannucci PM. Intramuscular anti-D
                          immunoglobulins for home treatment of chronic
                          immune thrombocytopenic purpura. Br J
                          Haematol. 1992 Mar;80(3):337-40.
 REFERENCES               Gringeri A, Santagostino E, Cattaneo M,
                          Simoni L, Tradati F. Anti-D immunoglobulins
                          (IgG) for long-term treatment of patients
                          with HIV-related or idiopathic immune
                          thrombocytopenic purpura (ITP). Int Conf
                          AIDS. 1991 Jun 16-21;7(1):267 (abstract no.
                          M.B.2340).
 REFERENCES               Bussel JB, Graziano JN, Kimberly RP, Pahwa S,
                          Aledort LM. Intravenous anti-D treatment of
                          immune thrombocytopenic purpura: analysis of
                          efficacy, toxicity, and mechanism of effect
                          [see comments]. Blood. 1991 May
                          1;77(9):1884-93.
 REFERENCES               Santagostino E, Cattaneo M, Capitanio A,
                          Gringeri A, Tradati F, Mannucci PM. Anti-D
                          immunoglobulin for treatment of immune
                          thrombocytopenic purpura (ITP): comparison
                          between HIV-related ITP and idiopathic ITP.
                          Int Conf AIDS. 1990 Jun 2-23;6(2):208
                          (abstract no. F.B.521).
 REFERENCES               Babu PG, Cherian T, Jairaj PK, Jayakumari H,
                          John TJ. Lack of evidence for seroconversion
                          to human immunodeficiency virus in recipients
                          of anti-D immunoglobulin containing HIV
                          antibody. Indian J Med Res. 1990 Mar;91:81-3.
 ENTRY MONTH              9311
 LAST REVISION DATE       960405
 

SOURCE: National Library of Medicine, Bethesda, MD.  Distributed by AEGIS.
